{"id":"https://openalex.org/W2980468852","doi":"https://doi.org/10.1182/blood-2018-99-114457","title":"A Novel Cell Line, Tnet-2, Derived from \"Triple-Negative\" Essential Thrombocythemia","display_name":"A Novel Cell Line, Tnet-2, Derived from \"Triple-Negative\" Essential Thrombocythemia","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2980468852","doi":"https://doi.org/10.1182/blood-2018-99-114457","mag":"2980468852"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-114457","doi":"https://doi.org/10.1182/blood-2018-99-114457","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-114457","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110719375","display_name":"Satoru Aoyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoru Aoyama","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan","Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Bunkyo-Ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]},{"raw_affiliation_string":"Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Bunkyo-Ku, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071276592","display_name":"Toshikage Nagao","orcid":"https://orcid.org/0000-0002-1766-3842","observed_orcids":["https://orcid.org/0000-0002-1766-3842"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Toshikage Nagao","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001274498","display_name":"Shunichiro Yasuda","orcid":"https://orcid.org/0009-0004-3958-7870","observed_orcids":["https://orcid.org/0009-0004-3958-7870"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shunichiro Yasuda","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan","Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]},{"raw_affiliation_string":"Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045763682","display_name":"Daisuke Watanabe","orcid":"https://orcid.org/0000-0002-8831-5765","observed_orcids":["https://orcid.org/0000-0002-8831-5765"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Daisuke Watanabe","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan","Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]},{"raw_affiliation_string":"Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004981982","display_name":"Hiroki Akiyama","orcid":"https://orcid.org/0000-0003-2627-1055","observed_orcids":["https://orcid.org/0000-0003-2627-1055"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroki Akiyama","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113176443","display_name":"Shinya Ishida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shinya Ishida","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103687414","display_name":"Ayako Nogami","orcid":"https://orcid.org/0009-0002-6374-3138","observed_orcids":["https://orcid.org/0009-0002-6374-3138"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Ayako Nogami","raw_affiliation_strings":["Laboratory Medicine, TMDU, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Medicine, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002230786","display_name":"Yoshihiro Umezawa","orcid":"https://orcid.org/0000-0003-1027-1552","observed_orcids":["https://orcid.org/0000-0003-1027-1552"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshihiro Umezawa","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065876841","display_name":"Ken Watanabe","orcid":"https://orcid.org/0000-0002-9752-6476","observed_orcids":["https://orcid.org/0000-0002-9752-6476"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Ken Watanabe","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087127498","display_name":"Masahide Yamamoto","orcid":"https://orcid.org/0000-0002-3142-8806","observed_orcids":["https://orcid.org/0000-0002-3142-8806"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]},{"id":"https://openalex.org/I4210161548","display_name":"Institute of Science Tokyo Hospital","ror":"https://ror.org/058548196","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210161548","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masahide Yamamoto","raw_affiliation_strings":["Department of Hematology, Tokyo Medical and Dental University Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Tokyo Medical and Dental University Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781","https://openalex.org/I4210161548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074139458","display_name":"Osamu Miura","orcid":"https://orcid.org/0000-0002-0981-3054","observed_orcids":["https://orcid.org/0000-0002-0981-3054"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Osamu Miura","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061189755","display_name":"Norihiko Kawamata","orcid":"https://orcid.org/0000-0003-1714-4097","observed_orcids":["https://orcid.org/0000-0003-1714-4097"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norihiko Kawamata","raw_affiliation_strings":["Department of Hematology, TMDU, Tokyo, Japan","Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, TMDU, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]},{"raw_affiliation_string":"Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001274498","https://openalex.org/A5002230786","https://openalex.org/A5004981982","https://openalex.org/A5045763682","https://openalex.org/A5065876841","https://openalex.org/A5071276592","https://openalex.org/A5087127498","https://openalex.org/A5103687414","https://openalex.org/A5113176443"],"corresponding_institution_ids":["https://openalex.org/I125602781","https://openalex.org/I4210161548"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"5493","last_page":"5493"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":0.8949999809265137},{"id":"https://openalex.org/keywords/clonal-hematopoietic-disorders","display_name":"clonal hematopoietic disorders","score":0.7360000014305115},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.5640000104904175},{"id":"https://openalex.org/keywords/flt3-mutation","display_name":"FLT3 mutation","score":0.37599998712539673},{"id":"https://openalex.org/keywords/ruxolitinib-resistance","display_name":"ruxolitinib resistance","score":0.8889999985694885},{"id":"https://openalex.org/keywords/blastic-transformation","display_name":"blastic transformation","score":0.6449999809265137},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.6259999871253967},{"id":"https://openalex.org/keywords/allogeneic-transplantation","display_name":"allogeneic transplantation","score":0.47099998593330383},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.6264915466308594},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.5342183709144592},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.5340079069137573},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5226335525512695},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5113398432731628},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.4425722658634186},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.42340680956840515},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4101332128047943},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3232455253601074},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2896304130554199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.217420756816864},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.12896671891212463}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-114457","doi":"https://doi.org/10.1182/blood-2018-99-114457","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-114457","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2946051233","https://openalex.org/W2611275719","https://openalex.org/W2997325246","https://openalex.org/W3138141503","https://openalex.org/W4250949774","https://openalex.org/W2991258914","https://openalex.org/W3096827862","https://openalex.org/W4412973877","https://openalex.org/W2187320767","https://openalex.org/W2203425936"],"abstract_inverted_index":{"Abstract":[0],"\u3010Introduction":[1],"\u3011":[2,194,240,419],"Myeloproliferative":[3],"neoplasm":[4],"(MPN)":[5],"is":[6,24,93,492],"a":[7,160,198,439,493,522],"heterogeneous":[8],"group":[9],"of":[10,28,37,41,48,167,227,381,389,426,442,448,469,500,511,545],"disorders,":[11],"including":[12,147,347,370,405],"Polycythemia":[13],"Vera":[14],"(PV),":[15],"Essential":[16],"Thrombocythemia":[17],"(ET)":[18],"and":[19,135,192,208,257,268,313,351,373,401,408,413,445,502,528,537],"Primary":[20],"Myelofibrosis":[21],"(PMF).":[22],"It":[23,57,420],"known":[25],"that":[26,60,424],"mutations":[27,45,281,290,298,322],"JAK2,":[29,326],"CALR,":[30],"or":[31,108,225,237,328],"MPL":[32],"gene":[33,444],"are":[34,73,102,431,477],"causative":[35],"alternations":[36,63,425],"MPNs.":[38],"However,":[39,410],"10-15%":[40],"MPNs":[42],"have":[43,112,157,171,196,245,461],"no":[44,94,478],"in":[46,129,188,222,248,282,303,310,318,325,336,357,368,433,452,538],"any":[47],"these":[49,456],"three":[50],"genes,":[51],"so-called":[52],"\"triple":[53],"negative\"":[54],"(TN)":[55],"MPN.":[56],"remains":[58],"unclear":[59],"what":[61],"genetic":[62,458],"cause":[64],"TN-MPN.":[65],"Cell":[66,391],"lines":[67,104],"derived":[68,97,525],"from":[69,98,163,203,526],"clonal":[70],"hematopoietic":[71],"disorders":[72],"useful":[74,494],"tools":[75],"to":[76,82,139,152,399,496,547],"characterize":[77,497],"diseases":[78],"as":[79,81,185,187,384,386],"well":[80,186,385],"identify":[83],"effective":[84],"reagents":[85,404],"for":[86,360,486,507,517],"such":[87],"diseases.":[88],"To":[89],"our":[90],"knowledge,":[91],"there":[92,101],"cell":[95,161,175,200,270,416,490,523],"line":[96,162,176,491,524],"TN-MPN":[99,527],"although":[100],"several":[103],"with":[105,118,252,344,436],"JAK2":[106],"V617F":[107],"CALR":[109,329],"mutation.":[110],"We":[111,156,170,195],"encountered":[113],"an":[114,482],"aggressive":[115],"ET":[116],"case":[117],"TN":[119],"phenotype.":[120],"Three":[121],"years":[122],"after":[123],"initial":[124],"diagnosis,":[125],"blastic":[126],"transformation":[127],"occurred":[128],"this":[130,168,498,508],"patient.":[131,142,169],"Both":[132],"conventional":[133,402],"chemotherapy":[134],"allogeneic":[136],"transplantation":[137],"failed":[138,151],"cure":[140],"the":[141,154,164,174,204,223,269,437,518],"After":[143],"relapse,":[144],"various":[145],"therapies":[146],"ruxolitinib":[148,400],"(JAK":[149],"inhibitor)":[150],"control":[153],"disease.":[155,512],"successfully":[158],"established":[159,197,521],"leukemic":[165,205,243],"cells":[166,244,260,396],"also":[172,364],"characterized":[173],"by":[177,534],"whole":[178],"genome":[179],"sequencing":[180,183],"(WGS),":[181],"RNA":[182],"(RNA-Seq),":[184],"vitro":[189,539],"assays.":[190,540],"\u3010Material":[191],"Methods":[193],"novel":[199,489,504,530],"line,":[201,271],"TNET-2,":[202,272],"cells.":[206,454],"WGS":[207,276],"RNA-Seq":[209,377,536],"were":[210,220,261,295,301,308,316,323,353,363,375,397,450],"performed":[211,221],"at":[212],"Beijing":[213],"Genome":[214],"Institute":[215],"(BGI)":[216],"Japan.":[217],"Proliferation":[218],"assays":[219,393],"presence":[224],"absence":[226],"ruxolitinib,":[228],"AC220":[229,412],"(FLT3":[230],"inhibitor),":[231,234],"giltertinib":[232,414],"(FLT3/AXL":[233],"etoposide,":[235,406],"cytarabine":[236,407],"hydroxycarbamide.":[238,409],"\u3010Results":[239],"The":[241,259],"patient's":[242],"been":[246,274,422],"cultured":[247],"RPMI1640":[249],"culture":[250],"media":[251],"10%":[253],"fetal":[254],"bovine":[255],"serum":[256],"antibiotics.":[258],"exponentially":[262],"growing":[263],"more":[264,463],"than":[265,464],"one":[266],"year":[267],"has":[273,277,421],"established.":[275],"found":[278,302,309,317,324,335,462,529],"116":[279],"missense":[280],"110":[283],"genes":[284,312,340,430],"encoding":[285,341],"proteins.":[286],"Also,":[287],"five":[288],"nonsense":[289,332,440],"causing":[291,299],"early":[292],"termination":[293],"codons":[294],"found.":[296],"InDel":[297],"frame-shifts":[300],"28":[304],"genes.":[305,320,467],"In-frame":[306],"deletions":[307],"seven":[311],"in-frame":[314],"insertions":[315],"nine":[319],"No":[321,542],"MPL,":[327],"gene.":[330,338],"A":[331],"mutation":[333,441],"was":[334],"ASXL1":[337,427,443],"Multiple":[339],"proteins":[342],"associated":[343],"myeloid":[345],"proliferation/differentiation,":[346],"CBL,":[348],"A-RAF,":[349],"HOXB9":[350],"BCL11B,":[352],"mutated.":[354,365,376],"Genes":[355,366],"involved":[356,367],"DNA":[358],"repair,":[359],"example":[361],"ERCC6,":[362],"apoptosis":[369],"CASP7,":[371],"TRAK1":[372],"SOCS3":[374],"revealed":[378],"high":[379],"expression":[380,388,447],"IRAK1":[382],"mRNA":[383],"low":[387,446],"TET2.":[390],"proliferation":[392],"showed":[394],"TNET-2":[395,453],"resistant":[398],"chemotherapeutic":[403],"both":[411],"induced":[415],"death.":[417],"\u3010Discussion":[418],"reported":[423],"and/or":[428],"TET2":[429,449],"common":[432],"TN-MPNs.":[434,487],"Consistent":[435],"reports,":[438],"detected":[451],"Besides":[455],"well-known":[457],"changes,":[459],"we":[460,515],"150":[465],"mutated":[466],"Some":[468],"them":[470],"seem":[471],"\"actionable\"":[472],"/":[473],"\"targetable\"":[474],"mutations.":[475],"There":[476],"optimal":[479],"treatments":[480],"targeting":[481],"altered":[483,531],"signaling":[484,532],"pathway":[485],"Our":[488],"tool":[495],"subtype":[499],"MPN":[501],"find":[503],"treatment":[505],"options":[506],"rare":[509],"type":[510],"In":[513],"summary,":[514],"have,":[516],"first":[519],"time,":[520],"pathways":[533],"WGS,":[535],"Disclosures":[541],"relevant":[543],"conflicts":[544],"interest":[546],"declare.":[548]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-10-25T00:00:00"}